Hui Ding
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Genetics top 5%
- Glioma Diagnosis and Treatment
Papers in
- Biomaterials 13
- Nanoparticle-Based Drug Delivery 12
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Julia Y. Ljubimova (28 shared papers)Keith L. Black (23 shared papers)Eggehard Holler (23 shared papers)Rameshwar Patil (22 shared papers)José Portilla‐Arias (16 shared papers)Bindu M. Konda (9 shared papers)Satoshi Inoue (6 shared papers)Alexander V. Ljubimov (10 shared papers)
- Journals
- Journal of Controlled Release (3 papers)Biomaterials (3 papers)Investigative Ophthalmology & Visual Science (2 papers)Marine Drugs (2 papers)ACS Nano (2 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Hui Ding
58 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 123
- Biomaterials 793
- Genetics 196
- Biomedical Engineering 680
- Pharmaceutical Science 84
- Molecular Biology 834
Countries citing papers authored by Hui Ding
This map shows the geographic impact of Hui Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Ding more than expected).
Fields of papers citing papers by Hui Ding
This network shows the impact of papers produced by Hui Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Ding. The network helps show where Hui Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 263 | |
| 2 | 2010 | 154 | |
| 3 | 2010 | 151 | |
| 4 | 2010 | 96 | |
| 5 | 2015 | 82 | |
| 6 | 2010 | 80 | |
| 7 | 2012 | 74 | |
| 8 | 2019 | 74 | |
| 9 | 2019 | 69 | |
| 10 | 2007 | 66 | |
| 11 | 2016 | 65 | |
| 12 | 2011 | 57 | |
| 13 | 2011 | 53 | |
| 14 | 2012 | 52 | |
| 15 | 2013 | 48 | |
| 16 | 2010 | 46 | |
| 17 | 2016 | 45 | |
| 18 | 2023 | 42 | |
| 19 | 2013 | 41 | |
| 20 | 2019 | 40 |
About Hui Ding
Hui Ding is a scholar working on Biomaterials, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Oncology and Genetics, having authored 58 papers that have together received 2.2k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (12 papers), Nanoparticle-Based Drug Delivery (12 papers), Electrocatalysts for Energy Conversion (6 papers), Advanced biosensing and bioanalysis techniques (6 papers), Lipid Membrane Structure and Behavior (5 papers), Glioma Diagnosis and Treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Advanced battery technologies research (4 papers). The work is most often cited by research in Biomaterials (793 citations), Genetics (196 citations), Biomedical Engineering (680 citations), Pharmaceutical Science (84 citations) and Molecular Biology (834 citations). Hui Ding has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Julia Y. Ljubimova, Keith L. Black, Eggehard Holler, Rameshwar Patil, José Portilla‐Arias, Bindu M. Konda, Satoshi Inoue, Alexander V. Ljubimov, Kolja Wawrowsky and Jinwei Hu. Their work appears in journals such as Journal of Controlled Release, Biomaterials, Investigative Ophthalmology & Visual Science, Marine Drugs and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.